{"@id":"https://bioecon.ru/technology/ultra-stable-antibody-platform/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/ultra-stable-antibody-platform/","json":"https://en.bioecon.ru/api/v1/technology/ultra-stable-antibody-platform/index.json"},"id":"ultra-stable-antibody-platform","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/archisen/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/chitose/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/ultra-bio-corporation/","https://bioecon.ru/companies/musashi-paint-holdings-coltd/"]},"maturity":7,"name":"Ultra-Stable Antibody Platform","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"In silico stability engineering"},{"n":2,"title":"Thermostability screening"},{"n":3,"title":"Viscosity mitigation at high concentration"},{"n":4,"title":"Room temperature shelf-life validation"}],"summary":"Computational redesign and conformational stabilization of antibody variable and constant domains, creating rigid scaffolds with thermal melting transitions exceeding 85°C that enable ultra-high concentration formulations (\u003e200 mg/mL) and ambient shelf life.","url":"/technology/ultra-stable-antibody-platform/","verified":"2026-11-22"}